Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.7
3.0
Journals
JCM
Special Issues
Clinical Advances in Vascular and Endovascular Surgery
share announcement

Clinical Advances in Vascular and Endovascular Surgery

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Vascular Medicine".

Deadline for manuscript submissions: 26 December 2024 | Viewed by 765

Special Issue Editor

Prof. Dr. Toshifumi Kudo

E-Mail Website
Guest Editor
Department of Cardiovascular Surgery, Division of Vascular Surgery, Tokyo Medical and Dental University, Tokyo, Japan
Interests: aortic aneurysm; peripheral arterial disease; chronic limb-threatening ischemia; endovascular anerysm repair; endovascular treatment; non-invasive blood flow measurements

Special Issue Information

Dear Colleagues,

The purpose of this Special Issue is to describe the current diagnostic methods and treatment outcomes for vascular diseases, particularly aortic aneurysms, peripheral artery diseases, and venous diseases, and identify current issues while also discussing possible solutions for the future. Regarding aortic aneurysms, including dissection, endovascular aneurysm repair (TEVAR/EVAR) has become the gold standard. We would particularly welcome authors to discuss complications, such as endoleaks, that influence treatment outcomes. For peripheral artery diseases, particularly CLTI, we would like authors to discuss a wide range of treatment methods, including bypass surgery, endovascular treatment (EVT), and foot care, aimed at improving treatment outcomes. Additionally, we would like authors to discuss the latest findings on venous diseases, such as varicose veins and deep vein thrombosis, as well as non-atherosclerotic peripheral artery diseases, including visceral artery aneurysms, popliteal artery entrapment syndrome, and adventitial cystic disease. This Special Issue welcomes original articles on vascular diseases, including those affecting the arteries and veins.

Prof. Dr. Toshifumi Kudo
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • aortic aneurysm
  • peripheral arterial disease
  • chronic limb-threatening ischemia
  • endovascular aneurysm repair
  • endovascular treatment
  • non-invasive blood flow measurements
  • varicose veins
  • deep venous thrombosis

Related Special Issue

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

13 pages, 1733 KiB  
Article
The Incidence and Outcomes of Major Limb Amputation in New Zealand from 2010 to 2021
by Odette Hart, Oliver Bernau and Manar Khashram
J. Clin. Med. 2024, 13(13), 3872; https://doi.org/10.3390/jcm13133872 - 30 Jun 2024
Viewed by 561
Abstract
Background: Major limb amputation (MLA) can be a common outcome due to severe peripheral artery disease (PAD) and diabetic foot disease (DFD), and it carries a significant mortality burden. In New Zealand (NZ), there is little documentation of the incidence rate and [...] Read more.
Background: Major limb amputation (MLA) can be a common outcome due to severe peripheral artery disease (PAD) and diabetic foot disease (DFD), and it carries a significant mortality burden. In New Zealand (NZ), there is little documentation of the incidence rate and mortality after MLA. The aim was to report the national crude and standardised rates and the mortality post MLA. Methods: This retrospective observational study included all MLAs that occurred within NZ from 1/1/2010 to 31/12/2021 due to DFD and/or PAD. Two national databases (National Minimum Dataset and the Australasian Vascular Audit) were utilised. The crude rates were calculated as cases per 100,000 in the NZ population per year including all ages (using the 2013 and 2018 NZ census figures). The age-standardised rates used the World Health Organization standard population. Post-operative mortality was calculated from the date of first hospitalisation for MLA. Results: From 2010 to 2021, there were 5293 MLA procedures in 4242 patients. On average, there were 8.5 MLAs per week and 441.1 MLAs annually. The overall crude rate was 9.44 per 100,000, and the standardised rate was 6.12 per 100,000. Over the 12 years, the crude rate decreased by 22% (p < 0.001), and the standardised rate decreased by 20.4% (p < 0.001). After MLA, the 30-day and 1-year mortality was 9.5% and 29.6%, respectively. From 2010 to 2021, the relative reduction in 30-day mortality was 45.1% (p < 0.001), and the reduction in 1-year mortality was 24.5% (p < 0.001). Increasing age, female sex and end-stage renal failure were predictors of 30-day and 1-year mortality. Conclusions: A considerable number of MLAs occur in NZ, with substantial perioperative mortality; however, the national incidence rates and mortality have improved over the last 12 years. This data might serve as benchmark to further reduce MLAs and improve patient outcomes. Full article
(This article belongs to the Special Issue Clinical Advances in Vascular and Endovascular Surgery)
►▼ Show Figures

Figure 1

Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop